28 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Pklrchar4/Pklrchar4 involves: A/J * C57BL/6	abnormal erythrocyte morphology	J:86735
	abnormal erythropoiesis	J:141722
	anemia	J:141722
	decreased hemoglobin content	J:141722
	decreased susceptibility to parasitic infection	J:86735, J:141722
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:141722
	enlarged spleen	J:86735
	hemolytic anemia	J:86735
	increased erythrocyte clearance	J:141722
	reticulocytosis	J:86735, J:141722
Pklrem1Appsc/Pklrem1Appsc involves: C57BL/6J	abnormal metabolism	J:342736
	abnormal sphingomyelin level	J:342736
	decreased ceramide level	J:342736
	decreased saturated fatty acids level	J:342736
	decreased susceptibility to diet-induced hepatic steatosis	J:342736
PklrM1Neu/PklrM1Neu involves: 101/El * C3H/El	no abnormal phenotype detected	J:65152
Pklrslc/Pklrslc CBA/NSlc-Pklrslc	abnormal common myeloid progenitor cell morphology	J:30035
	abnormal enzyme/coenzyme activity	J:29199
	abnormal erythropoiesis	J:30035, J:141722
	anemia	J:141722
	decreased erythrocyte cell number	J:30035
	decreased hematocrit	J:30035
	decreased hemoglobin content	J:30035, J:141722
	decreased susceptibility to parasitic infection	J:141722
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:141722
	enlarged spleen	J:30035
	hemolytic anemia	J:29199, J:30035
	hemosiderosis	J:30035
	increased circulating bilirubin level	J:30035
	increased erythroblast number	J:30035
	increased erythrocyte clearance	J:141722
	increased erythroid progenitor cell number	J:29199
	increased mean corpuscular volume	J:30035
	increased nucleated erythrocyte cell number	J:30035
	increased susceptibility to bacterial infection induced morbidity/mortality	J:128518
	reticulocytosis	J:30035, J:141722
Pklrslc/Pklrslc involves: CBA/NSlc	abnormal erythrocyte morphology	J:203909
	anemia	J:203909
	increased erythrocyte osmotic fragility	J:203909